Boston-based Vittamed wins CE Mark approval for devices to monitor intracranial pressure and cerebral perfusion.
Medtech maker Vittamed won CE Mark approval for a pair of ultrasound-based systems for monitoring intracranial pressure and cerebral perfusion, the company announced.
European regulators approved Vittamed's 205 intracranial pressure measurement and the 505 cerebrovascular autoregulation monitor, both of which use non-invasive headsets to monitor activity in the brain.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uKHkWL
Cap comentari:
Publica un comentari a l'entrada